News search

    E.g., 24/07/2026
    E.g., 24/07/2026
    Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
    Research
    22 May 2026
    Science Immunology: Mitochondria control immune cell activation and the effectiveness of immunotherapy

    A CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors
    Francesco Costa
    Research
    18 May 2026
    Dr. Francesco Costa: "The sustained use of tools like ChatGPT produces a phenomenon called deskilling"
    About the CNIC
    27 Apr 2026
    The First 2026 Competitive Call for Unique Scientific and Technical Infrastructures of the Distributed Biomedical Imaging Network (ReDIB) Is Now Open
    Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht
    Research
    23 Apr 2026
    Job Verdonschot: "The next challenge is the full integration of genetics into cardiology training programs"

    Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht
    Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
    Research
    21 Apr 2026
    CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure

    The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.
    COMPASS
    About the CNIC
    31 Mar 2026
    CNIC participates in COMPASS, a European project promoting the early detection and personalised treatment of cardiotoxicity in cancer patients

    The initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors 
    JACC_Journals
    About the CNIC
    30 Mar 2026
    The ACC recognises the research into cardiotoxicity carried out at the CNIC by Danielle Medina-Hernández

    The Young Author Achievement Award recognises her research into cardiotoxicity published in JACC: Cardio-Oncology
    Minna Kaikkonen-Määttä
    About the CNIC
    20 Mar 2026
    Minna Kaikkonen-Määttä: "Research is a unique career because you essentially get to be curious for a living and contribute to new knowledge that might eventually benefit society"
    Justin Perry
    About the CNIC
    5 Mar 2026
    Justin Perry: "In science, we are wrong all the time"

    Justin Perry, Associate Member in the Immunology Program of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center and an Assistant Professor in the Immunology and Microbial Pathogenesis Program at Weill Cornell Medical Center
    From left to right, Borja Ibáñez, Laura Cádiz, Agustín Clemente Moragón, Ángela Pollán, Lucía López Palomar, and Anabel Díaz Guerra.
    Research
    26 Feb 2026
    Basic Research in Cardiology: A CNIC study shows that the heart can be protected during chemotherapy without reducing antitumor efficacy

    The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines